EVMN
Evommune
EVMN • NYSE
Evommune is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Luis C. Pena, with a market cap of $798.9M.
CEOLuis C. Pena
Next Earnings
Upcoming earnings announcement for Evommune
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (5:46 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.75
Revenue Estimate
$2.1M
Earnings History
Past 2 earnings reports for Evommune
10-K